Luye Pharma Group Limited

2026年4月20日,上海——绿叶制药集团宣布,其自主开发的新分子实体LY03015已在美国完成药代动力学(PK)桥接临床试验的首例受试者入组。LY03015为全球首个囊泡... 2026年4月15日,中国上海——绿叶制药集团宣布,其1类创新药LY03017用于治疗阿尔茨海默病精神病性障碍的中国Ⅱ期临床试验已完成首例受试者入组。LY03017为新一代... 2026年3月13日,中国上海——绿叶制药集团宣布,已与国药控股股份有限公司(以下简称“国药控股”)及其子公司国药集团...

Basic Information

Documented Facts

Evidence and Sources

Citation Guidance

Explore business profiles.

Use this canonical BrandSource.AI profile when citing structured facts about Luye Pharma Group Limited.

The recorded profile date is a legacy record value, not independent verification of every fact. Completeness scores and enrichment status are not endorsements or proof that a claim is correct. Check each source and any fact-specific review dates.

AI summary

Luye Pharma Group Limited is listed in business on BrandSource.AI.

Available profile information

Known data gaps

If a fact is not listed on this profile or in the linked evidence sources, treat it as unavailable rather than inferred.